| Literature DB >> 24586736 |
Olga Tatarinova1, Vladimir Tsvetkov2, Dmitry Basmanov1, Nikolay Barinov1, Igor Smirnov1, Edward Timofeev3, Dmitry Kaluzhny3, Andrey Chuvilin3, Dmitry Klinov4, Anna Varizhuk5, Galina Pozmogova1.
Abstract
Noncanonically structured DNA aptamers to thrombin were examined. Two different approaches were used to improve stability, binding affinity and biological activity of a known thrombin-binding aptamer. These approaches are chemical modification and the addition of a duplex module to the aptamer core structure. Several chemically modified aptamers and the duplex-bearing ones were all studied under the same conditions by a set of widely known and some relatively new methods. A number of the thrombin-binding aptamer analogs have demonstrated improved characteristics. Most importantly, the study allowed us to compare directly the two approaches to aptamer optimization and to analyze their relative advantages and disadvantages as well as their potential in drug design and fundamental studies.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24586736 PMCID: PMC3930721 DOI: 10.1371/journal.pone.0089383
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic representation of the thrombin-binding aptamer and its chemical modifications.
Sequences, MALDI-TOF MS data, GQ melting temperatures and thrombin-time values of chemically modified TBA analogs.
| aptamer | sequence, 5’–3’ | m/z, found (calculated for [M + H]+) | Tm at 295 nm,°C | thrombin time, s |
| TBA |
| 4728 (4727) | 52±1 | 41±2 |
| thio-TBA | GGTthioTGGTGTGGTthioTGG | 4758 (4759) | 55±1 | 28±1 |
| triazole-TBA | GGTTGGTTtriazoleTGGTTGG | 4674 (4674) | 42±1 | 31±1 |
| alpha-TBA | GGTTGGalpha-TG alpha-TGGTTGG | 4725 (4727) | 42±1 | 25±1 |
| f-thio-TBA | GthioGthioTthioTthioGthioGthioTthioGthio TthioGthioGthioTthioTthioGthioG | 4952(4951) | 45±1 | 11±1 |
* the same as without any ON.
**The triazole-TBA sequence is different from that of TBA (the central loop is TTT instead of TGT) because the modified fragment could only be introduced using the dithymidine triazole-containing phosphoramidite block. The slightly decreased biological activity of triazole-TBA can thus be partially attributed to the change of the sequence.
Figure 2Evaluation of thrombin/aptamer interactions using PC SW biosensors.
Delta H = increment of the effective adlayer thickness. A: Sensorgrams obtained upon aptamer binding with surface-immobilized thrombin. Delta H is normalized to thrombin adlayer effective thickness of 1 nm. B: Comparison of specific and nonspecific binding. Random ON is a G-rich ON of about the same length as TBA, which does not adopt monomolecular G-quadruplex structure under the specified conditions, as was proven by CD and UV-melting studies (Random ON = GGGAGGCTGATTCAGG). C: Sensorgrams obtained upon thrombin binding with surface-immobilized biotinylated TBA. Thr = thrombin. Delta H is normalized to the effective aptamer adlayer thickness of 0.25 nm. D: Sensorgrams obtained upon thrombin binding with surface-immobilized biotinylated thio-TBA. Delta H is normalized to the aptamer adlayer thickness of 0.5 nm. All experiments were performed in duplicate. Saturation level deviation did not exceed 5%.
Figure 3Thio-TBA/thrombin MD simulation results.
A: The snapshot taken at 10 ns of RR thio-TBA/thrombin dynamics simulation. The aptamer does not dissociate from the protein, and no significant distortions in GQ structure can be seen. Red dotted lines are H-bonds. B: Plots of the thrombin-aptamer binding energy: the total binding energy (top) and the van-der-Waals contribution (bottom).
Figure 4Schematic representation of TBA analogs with a duplex module and flanks.
Sequences, MALD-TOF MS data and thrombin-time values of TBA analogs with a duplex module and flanks.
| aptamer | sequence, 5’–3’ | m/z, found (calculated for [M + H]+) | thrombin time, s |
| 31TBA |
| 9710 (9711) | 62±2 |
| ssf-TBA31 | TCACCTGCACGCCAAGTGTG | 18984(18981) | 30±1 |
| dsf-TBA31 | Strand 1 = ssf-TBA31, Strand 2: | strand2:15430 (15429) | 62±1 |
| NegContr | Strand1:TCACCTGCACGC CAAGTGTGCGCCAAGTGTG; Strand 2 = that of dsf-TBA31 | strand1:9498 (9498) | 11±1 |
* The TBA31 fragment is in bold. Overhanging single-stranded fragments of dsf-TBA31 Strand 2 are in Italics. The overhangs (sticky ends) were introduced in dsf-TBA31 structure to open up the possibility for the assembly of polyvalent supramolecular structures.
** the same as without any ON.
Figure 5The assembly of dsf-TBA31 and its binding with thrombin.
A: EMSA results illustrating the formation of the intermolecular dsf-TBA31 structure and its complex with thrombin. 1– ssf-TBA31; 2 and 3– dsf-TBA-31 (ssf-TBA-31+ strand 2); 4– strand 2 of dsf-TBA31; 5– ssf-TBA31+ thrombin; 6 and 7– dsf-TBA31+ thrombin. B: PCSW-sensorgrams illustrating dsf-TBA31 binding with thrombin. The sensorgrams were obtained upon aptamer interaction with surface-immobilized protein. Random ON = GGGAGGCTGATTCAGG. Delta H = increment of the effective adlayer thickness.
Comparison of the two approaches to DNA ligand optimization.
| aptamer characteristics | approach 1 (chemical modification) | approach 2 (addition of a duplex) |
| enhanced thermostability | ± | + |
| resistance to biodegradation | + | not analyzed |
| enhanced affinity to target protein | ± | − |
| resemblance to | − | + |